Atopic dermatitis is associated with a fivefold increased risk of polysensitisation in children

Suzanne A Broeks1, Paul L P Brand2,3

  • 1Department of Internal Medicine, ZGT Hospital, Almelo, The Netherlands.

Insights

Children with atopic dermatitis have a significantly higher risk of polysensitisation, meaning they are sensitised to five or more allergens. This finding supports the theory of a compromised skin barrier facilitating allergen exposure.

Area of Science:

  • Allergy and Immunology
  • Dermatology
  • Pediatrics

Background:

  • A dysfunctional skin barrier in atopic dermatitis may lead to increased allergen exposure.
  • Polysensitisation, defined as allergic sensitisation to five or more allergens, is a growing concern.

Purpose of the Study:

  • To investigate the association between atopic dermatitis and the likelihood of polysensitisation in children.
  • To determine if atopic dermatitis increases the risk of developing allergies to multiple common allergens.

Main Methods:

  • Retrospective analysis of electronic hospital records for 1743 children (aged 0-17) with allergic symptoms.
  • Measurement of specific immunoglobulin E (IgE) levels against 10 common inhaled and food allergens.
  • Comparison of polysensitisation rates between children with and without atopic dermatitis, adjusting for age and gender.

Main Results:

  • Polysensitisation was significantly more prevalent in children with atopic dermatitis (22.4%) compared to those without (5.5%, p < 0.001).
  • Atopic dermatitis was independently associated with an increased odds of polysensitisation (OR: 5.63, 95% CI: 3.77-8.40).
  • Other skin disorders did not demonstrate a similar increased risk for polysensitisation.

Conclusions:

  • Polysensitisation is considerably more common in children diagnosed with atopic dermatitis.
  • These findings support the hypothesis that a defective skin barrier in atopic dermatitis facilitates allergen sensitisation.
  • The increased risk of polysensitisation appears specific to atopic dermatitis.
Abstract

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
Allergic Reactions02:06

Allergic Reactions

Overview
33.1K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.0K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
96
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K